Mallinckrodt shares drop after U.S. joins cases over expensive drug

The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.

…read more

Source:: Reuters – Business News